ASCO GI 2026: Matterhorn

Expert-led insights in gastric and GEJ cancers highlight evolving treatment strategies, including perioperative and advanced disease management. Focus on integrating emerging data into sequencing and personalized clinical decision-making.

Ep. 4: Next-Line Strategies and Practice Insights for Durvalumab in Gastric and GEJ Cancer

Rahul Gosain, MD, MBA, Rohit Gosain, MD, Angela Alistar, MD, Steven Maron, MD, MSc, Reetu Mukherji, MD, Raji Shameem, MD

Ep. 3: Balancing Therapy Intensity and Patient Tolerability in Gastric and GEJ Cancer

Rahul Gosain, MD, MBA, Rohit Gosain, MD, Angela Alistar, MD, Steven Maron, MD, MSc, Reetu Mukherji, MD, Raji Shameem, MD

Ep. 2: Up-Front PD-L1 Testing and Perioperative Immunotherapy in Gastric and GEJ Cancer

Rahul Gosain, MD, MBA, Rohit Gosain, MD, Angela Alistar, MD, Steven Maron, MD, MSc, Reetu Mukherji, MD, Raji Shameem, MD

Ep. 1: Clinical Insights on Perioperative Durvalumab in Gastric and GEJ Cancer

Rahul Gosain, MD, MBA, Rohit Gosain, MD, Angela Alistar, MD, Steven Maron, MD, MSc, Reetu Mukherji, MD, Raji Shameem, MD

Perioperative Durvalumab: The New Standard for Gastric or GEJ Cancer

Angela Alistar, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD, Steven Maron, MD, MSc, Reetu Mukherji, MD, Raji Shameem, MD